Newsfeeds - Spark Newswire

4 minute read

Adagene Highlights Presentation Of Data On Its Preclinical Antibody Candidates At American Association For Cancer Research Meeting

Today, 8:42 AM

- Poster presentations showcase SAFEbody® precision masking technology applicability across targets and modalities – - IND or equivalent filings planned for two new product candidates in 2022, including

ADAG

6 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 8:42 AM

On Thursday, 92 companies hit new 52-week lows.

ABOS

3 minute read

The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study

By Shanthi Rexaline

Today, 8:42 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ADAG

27 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 8:42 AM

During Tuesday's session, 454 stocks hit new 52-week lows.

ADAG

13 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 8:42 AM

During Friday's session, 198 companies made new 52-week lows.

ACLX

1 minute read

Chinese Stocks Down ~2-3% Thursday; Western Media Thursday Morning Highlights Chinese Stance On Russian Invasion Could Be Becoming Less Neutral, Highlights Misinformation Being Shared By Chinese State To Chinese Citizens

By Benzinga Newsdesk

Today, 8:42 AM

https://www.cnn.com/2022/03/10/china/china-russia-disinformation-campaign-ukraine-intl-dst-hnk/index.html

ACH

22 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 8:42 AM

On Friday, 368 stocks hit new 52-week lows.

AAL

2 minute read

67 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:42 AM

Losers

ADAG

1 minute read

Morgan Stanley Maintains Overweight on Adagene, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 8:42 AM

Morgan Stanley analyst Matthew Harrison maintains Adagene (NASDAQ:ADAG) with a Overweight and lowers the price target from $27 to $15.

ADAG

4 minute read

The Daily Biotech Pulse: Adagio’s Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact

By Shanthi Rexaline

Today, 8:42 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADAG